Globus Income Statement Research

GMED Stock

USD 64.72 0.36 0.56%

Most accounts from Globus Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Globus Medical Valuation and Globus Medical Correlation analysis.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

At present, Globus Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 1.6 B, whereas EBIT is forecasted to decline to about 168.5 M.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 1.6 B, whereas EBIT is forecasted to decline to about 168.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	718.9M	759.1M	1.0B	533.4M
Total Revenue	958.1M	1.0B	1.6B	1.6B

Gross Profit Total Revenue

Globus Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.85	0.97	0.81	0.97	0.37	0.64	0.99	0.79	0.95	0.98	0.48	0.83	0.54	-0.03	0.97	0.57	0.4	0.75	-0.64	0.88	0.76	0.82	0.74
Interest Expense	0.85		0.89	0.81	0.88	0.46	0.66	0.88	0.74	0.84	0.91	0.61	0.73	0.69	-0.11	0.91	0.72	0.24	0.96	-0.77	0.97	0.96	0.69	0.6
Total Revenue	0.97	0.89		0.81	1.0	0.42	0.72	0.97	0.8	0.99	1.0	0.54	0.9	0.56	0.08	1.0	0.59	0.31	0.8	-0.59	0.86	0.8	0.82	0.8
Gross Profit	0.81	0.81	0.81		0.79	0.55	0.87	0.82	0.98	0.74	0.82	0.7	0.59	0.75	0.05	0.82	0.72	0.37	0.77	-0.57	0.84	0.86	0.84	0.62
Other Operating Expenses	0.97	0.88	1.0	0.79		0.36	0.68	0.97	0.77	0.99	1.0	0.48	0.92	0.51	0.04	1.0	0.54	0.3	0.79	-0.59	0.85	0.79	0.84	0.82
Operating Income	0.37	0.46	0.42	0.55	0.36		0.69	0.35	0.6	0.29	0.4	0.98	0.1	0.92	0.51	0.4	0.89	0.08	0.5	-0.23	0.49	0.42	0.12	-0.04
Ebit	0.64	0.66	0.72	0.87	0.68	0.69		0.62	0.94	0.66	0.69	0.79	0.52	0.76	0.36	0.69	0.72	0.36	0.65	-0.26	0.62	0.67	0.68	0.57
Research Development	0.99	0.88	0.97	0.82	0.97	0.35	0.62		0.77	0.94	0.98	0.47	0.83	0.54	-0.08	0.97	0.57	0.36	0.8	-0.72	0.9	0.8	0.81	0.73
Ebitda	0.79	0.74	0.8	0.98	0.77	0.6	0.94	0.77		0.73	0.79	0.72	0.57	0.74	0.17	0.79	0.71	0.43	0.7	-0.44	0.76	0.77	0.82	0.63
Cost Of Revenue	0.95	0.84	0.99	0.74	0.99	0.29	0.66	0.94	0.73		0.98	0.41	0.95	0.42	0.08	0.98	0.46	0.26	0.73	-0.52	0.78	0.73	0.84	0.87
Total Operating Expenses	0.98	0.91	1.0	0.82	1.0	0.4	0.69	0.98	0.79	0.98		0.52	0.88	0.57	0.01	1.0	0.6	0.33	0.83	-0.64	0.89	0.82	0.82	0.78
Income Before Tax	0.48	0.61	0.54	0.7	0.48	0.98	0.79	0.47	0.72	0.41	0.52		0.22	0.96	0.43	0.52	0.94	0.13	0.65	-0.35	0.63	0.59	0.28	0.11
Total Other Income Expense Net	0.83	0.73	0.9	0.59	0.92	0.1	0.52	0.83	0.57	0.95	0.88	0.22		0.22	0.08	0.89	0.27	0.06	0.61	-0.39	0.63	0.63	0.81	0.93
Net Income	0.54	0.69	0.56	0.75	0.51	0.92	0.76	0.54	0.74	0.42	0.57	0.96	0.22		0.18	0.57	0.98	0.24	0.74	-0.54	0.74	0.7	0.32	0.1
Income Tax Expense	-0.03	-0.11	0.08	0.05	0.04	0.51	0.36	-0.08	0.17	0.08	0.01	0.43	0.08	0.18		0.02	0.14	-0.35	-0.13	0.53	-0.19	-0.2	-0.05	0.06
Selling General Administrative	0.97	0.91	1.0	0.82	1.0	0.4	0.69	0.97	0.79	0.98	1.0	0.52	0.89	0.57	0.02		0.6	0.31	0.83	-0.63	0.89	0.83	0.82	0.79
Net Income From Continuing Ops	0.57	0.72	0.59	0.72	0.54	0.89	0.72	0.57	0.71	0.46	0.6	0.94	0.27	0.98	0.14	0.6		0.21	0.77	-0.55	0.76	0.71	0.33	0.12
Non Recurring	0.4	0.24	0.31	0.37	0.3	0.08	0.36	0.36	0.43	0.26	0.33	0.13	0.06	0.24	-0.35	0.31	0.21		0.25	-0.33	0.36	0.24	0.28	0.13
Non Operating Income Net Other	0.75	0.96	0.8	0.77	0.79	0.5	0.65	0.8	0.7	0.73	0.83	0.65	0.61	0.74	-0.13	0.83	0.77	0.25		-0.78	0.94	0.93	0.57	0.48
Tax Provision	-0.64	-0.77	-0.59	-0.57	-0.59	-0.23	-0.26	-0.72	-0.44	-0.52	-0.64	-0.35	-0.39	-0.54	0.53	-0.63	-0.55	-0.33	-0.78		-0.83	-0.75	-0.4	-0.25
Interest Income	0.88	0.97	0.86	0.84	0.85	0.49	0.62	0.9	0.76	0.78	0.89	0.63	0.63	0.74	-0.19	0.89	0.76	0.36	0.94	-0.83		0.93	0.67	0.5
Net Interest Income	0.76	0.96	0.8	0.86	0.79	0.42	0.67	0.8	0.77	0.73	0.82	0.59	0.63	0.7	-0.2	0.83	0.71	0.24	0.93	-0.75	0.93		0.72	0.57
Reconciled Depreciation	0.82	0.69	0.82	0.84	0.84	0.12	0.68	0.81	0.82	0.84	0.82	0.28	0.81	0.32	-0.05	0.82	0.33	0.28	0.57	-0.4	0.67	0.72		0.9
Extraordinary Items	0.74	0.6	0.8	0.62	0.82	-0.04	0.57	0.73	0.63	0.87	0.78	0.11	0.93	0.1	0.06	0.79	0.12	0.13	0.48	-0.25	0.5	0.57	0.9

Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

Globus Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	17.4M	14.0M	9.3M	14.2M	20.1M	21.1M
Total Revenue	785.4M	789.0M	958.1M	1.0B	1.6B	1.6B
Gross Profit	605.4M	571.6M	718.9M	759.1M	1.0B	533.4M
Operating Income	172.0M	111.4M	172.0M	228.0M	133.1M	153.7M
Ebit	172.0M	111.4M	172.0M	228.0M	256.3M	168.5M
Research Development	60.1M	84.5M	97.3M	73.0M	124.0M	130.2M
Ebitda	230.0M	182.7M	289.1M	313.8M	401.0M	221.9M
Cost Of Revenue	180.0M	217.5M	239.2M	263.7M	548.2M	575.6M
Income Before Tax	189.9M	125.9M	180.4M	243.0M	165.4M	162.4M
Net Income	155.2M	102.3M	149.2M	190.2M	122.9M	117.3M
Income Tax Expense	34.7M	23.6M	31.2M	52.9M	42.5M	44.9M
Tax Provision	34.7M	23.6M	31.2M	52.9M	42.5M	34.9M
Net Interest Income	17.4M	14.0M	9.3M	14.2M	20.1M	13.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:

How To Invest In Globus

Details

Is Globus Stock a good investment?

Details

What is Globus Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Globus Medical Valuation and Globus Medical Correlation analysis.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.

	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.

Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.79)

Earnings Share

0.54

Revenue Per Share

15.579

Quarterly Revenue Growth

1.193

Return On Assets

0.0527

The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Globus Income Statement Research

Globus Medical income statement Correlations

Globus Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Globus Medical income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Globus Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Total Revenue
Selling General Administrative	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Selling General Administrative	+ 1.0	Other Operating Expenses
Selling General Administrative	+ 1.0	Total Operating Expenses

Interest Income	- 0.83	Tax Provision
Tax Provision	- 0.78	Non Operating Income Net Other
Tax Provision	- 0.77	Interest Expense
Net Interest Income	- 0.75	Tax Provision
Tax Provision	- 0.72	Research Development
Tax Provision	- 0.64	Total Operating Expenses